I work in drug development, and I have firsthand experience with the urgency and importance of reliable clinical data for patients who depend on it for life-saving treatments. The recent expansion of prediction markets, such as Kalshi, to include wagers on clinical trial outcomes and regulatory decisions threatens the very foundation of trust and integrity in biotechnology.

By treating clinical development milestones as binary betting events, prediction markets introduce systemic moral hazards that can severely compromise the authenticity of clinical data. When clinical trial results are reduced to mere gambling odds, the risk of manipulating or misrepresenting data increases significantly. This can lead to false confidence in unproven therapies or unwarranted skepticism towards legitimate innovations, ultimately harming patients who depend on accurate information.

Moreover, the devaluation of clinical trial integrity further erodes the trust that the biotechnology industry has diligently built with patient communities. These relationships, founded on transparency and reliability, are essential for effective patient recruitment and retention, as well as the success of public health initiatives.

The dangers of unregulated prediction markets in healthcare are clear. Industry, regulators, and stakeholders must come together to establish strict guidelines that prevent potential abuses and protect patient interests. A regulatory framework needs to be enacted to ensure that prediction markets do not compromise clinical trial integrity. Policies should be put in place to prohibit speculative betting on clinical outcomes and to preserve the sanctity of clinical research.

Everyone who is part of the healthcare ecosystem, from researchers to patients and advocates, has a stake in keeping clinical research untainted and trustworthy. We cannot allow the promise of financial gain to overshadow our moral obligation to patient welfare and public health.

Sign this petition to urge regulators to act decisively and ensure the protection of clinical trial integrity by regulating prediction markets that gamble on critical health milestones. Your support is crucial in maintaining trust and safeguarding the future of medical innovation.